HDAC9 and cancer: The nanodrugs can not only promote cancer cell apoptosis through HDAC inhibition‐enhanced oxidation therapy but also reshape the immunosuppressive microenvironment, which provides a novel strategy to synergize oxidation therapy with epigenetic modulation for safe and efficient cancer therapy.